Proteasome Inhibitors Market 2025-2029

The proteasome inhibitors market is forecasted to grow by USD 4.41 billion during 2024-2029, accelerating at a CAGR of 8.4% during the forecast period. The report on the proteasome inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of hematologic cancers, growing prevalence of multiple myeloma, and expanded application of proteasome inhibitors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The proteasome inhibitors market is segmented as below:

By Product

VELCADE
KYPROLIS
NINLARO
Others

By Route Of Administration

Oral
Intravenous

By End-user

Hospitals
Cancer treatment centers
Specialty clinics
Research institutes

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in drug development as one of the prime reasons driving the proteasome inhibitors market growth during the next few years. Also, special drug designation for proteasome inhibitors by regulatory agencies and huge unmet need for certain cancer therapeutics will lead to sizable demand in the market.

The report on the proteasome inhibitors market covers the following areas:

Proteasome Inhibitors Market sizing
Proteasome Inhibitors Market forecast
Proteasome Inhibitors Market industry analysis

A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proteasome inhibitors market vendors that include Amgen Inc., Baxter International Inc., Bristol Myers Squibb Co., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson, Kezar Life Sciences Inc., LifeSensors Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., QLi5 Therapeutics, Takeda Pharmaceutical Co. Ltd., TG Therapeutics Inc., Thermo Fisher Scientific Inc., and Tocris Bioscience. Also, the proteasome inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis

4 Market Sizing

4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Proteasome Inhibitors Market 2019 - 2023
Historic Market Size - Data Table on Global Proteasome Inhibitors Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Proteasome Inhibitors Market

7 Five Forces Analysis

7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 VELCADE - Market size and forecast 2024-2029
Chart on VELCADE - Market size and forecast 2024-2029 ($ million)
Data Table on VELCADE - Market size and forecast 2024-2029 ($ million)
Chart on VELCADE - Year-over-year growth 2024-2029 (%)
Data Table on VELCADE - Year-over-year growth 2024-2029 (%)
8.4 KYPROLIS - Market size and forecast 2024-2029
Chart on KYPROLIS - Market size and forecast 2024-2029 ($ million)
Data Table on KYPROLIS - Market size and forecast 2024-2029 ($ million)
Chart on KYPROLIS - Year-over-year growth 2024-2029 (%)
Data Table on KYPROLIS - Year-over-year growth 2024-2029 (%)
8.5 NINLARO - Market size and forecast 2024-2029
Chart on NINLARO - Market size and forecast 2024-2029 ($ million)
Data Table on NINLARO - Market size and forecast 2024-2029 ($ million)
Chart on NINLARO - Year-over-year growth 2024-2029 (%)
Data Table on NINLARO - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Intravenous - Market size and forecast 2024-2029
Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
Chart on Intravenous - Year-over-year growth 2024-2029 (%)
Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by End-user

10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Cancer treatment centers - Market size and forecast 2024-2029
Chart on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Data Table on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Chart on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
Data Table on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
10.5 Specialty clinics - Market size and forecast 2024-2029
Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
10.6 Research institutes - Market size and forecast 2024-2029
Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)

11 Market Segmentation by Distribution Channel

11.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
11.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
11.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
11.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
11.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
11.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

12 Customer Landscape

12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.11 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
13.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.16 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints

15 Competitive Landscape

15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
Companies covered
16.2 Company ranking index
Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
16.5 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
SWOT
16.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
16.7 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
SWOT
16.8 Johnson and Johnson
Johnson and Johnson - Overview
Johnson and Johnson - Business segments
Johnson and Johnson - Key news
Johnson and Johnson - Key offerings
Johnson and Johnson - Segment focus
SWOT
16.9 Kezar Life Sciences Inc.
Kezar Life Sciences Inc. - Overview
Kezar Life Sciences Inc. - Product / Service
Kezar Life Sciences Inc. - Key offerings
SWOT
16.10 LifeSensors Inc.
LifeSensors Inc. - Overview
LifeSensors Inc. - Product / Service
LifeSensors Inc. - Key offerings
SWOT
16.11 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
16.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.14 QLi5 Therapeutics
QLi5 Therapeutics - Overview
QLi5 Therapeutics - Product / Service
QLi5 Therapeutics - Key offerings
SWOT
16.15 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
16.16 TG Therapeutics Inc.
TG Therapeutics Inc. - Overview
TG Therapeutics Inc. - Product / Service
TG Therapeutics Inc. - Key offerings
SWOT
16.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
16.18 Tocris Bioscience
Tocris Bioscience - Overview
Tocris Bioscience - Product / Service
Tocris Bioscience - Key offerings
SWOT

17 Appendix

17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
Research methodology
17.5 Data procurement
Information sources
17.6 Data validation
Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations
List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 9: Executive Summary - Chart on Incremental Growth
Exhibits 10: Executive Summary - Data Table on Incremental Growth
Exhibits 11: Executive Summary - Chart on Company Market Positioning
Exhibits 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 13: Overview on criticality of inputs and factors of differentiation
Exhibits 14: Overview on factors of disruption
Exhibits 15: Impact of drivers and challenges in 2024 and 2029
Exhibits 16: Parent Market
Exhibits 17: Data Table on - Parent Market
Exhibits 18: Market characteristics analysis
Exhibits 19: Value chain analysis
Exhibits 20: Offerings of companies included in the market definition
Exhibits 21: Market segments
Exhibits 22: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 26: Historic Market Size - Data Table on Global Proteasome Inhibitors Market 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 33: Five forces analysis - Comparison between 2024 and 2029
Exhibits 34: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 37: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 38: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 39: Chart on Market condition - Five forces 2024 and 2029
Exhibits 40: Chart on Product - Market share 2024-2029 (%)
Exhibits 41: Data Table on Product - Market share 2024-2029 (%)
Exhibits 42: Chart on Comparison by Product
Exhibits 43: Data Table on Comparison by Product
Exhibits 44: Chart on VELCADE - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on VELCADE - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on VELCADE - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on VELCADE - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on KYPROLIS - Market size and forecast 2024-2029 ($ million)
Exhibits 49: Data Table on KYPROLIS - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Chart on KYPROLIS - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on KYPROLIS - Year-over-year growth 2024-2029 (%)
Exhibits 52: Chart on NINLARO - Market size and forecast 2024-2029 ($ million)
Exhibits 53: Data Table on NINLARO - Market size and forecast 2024-2029 ($ million)
Exhibits 54: Chart on NINLARO - Year-over-year growth 2024-2029 (%)
Exhibits 55: Data Table on NINLARO - Year-over-year growth 2024-2029 (%)
Exhibits 56: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 60: Market opportunity by Product ($ million)
Exhibits 61: Data Table on Market opportunity by Product ($ million)
Exhibits 62: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 63: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 64: Chart on Comparison by Route of Administration
Exhibits 65: Data Table on Comparison by Route of Administration
Exhibits 66: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 70: Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Intravenous - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
Exhibits 74: Market opportunity by Route of Administration ($ million)
Exhibits 75: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 76: Chart on End-user - Market share 2024-2029 (%)
Exhibits 77: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 78: Chart on Comparison by End-user
Exhibits 79: Data Table on Comparison by End-user
Exhibits 80: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 81: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 83: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 84: Chart on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Exhibits 85: Data Table on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Chart on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
Exhibits 87: Data Table on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
Exhibits 88: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 89: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 90: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 91: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 92: Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 93: Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Chart on Research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 95: Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 96: Market opportunity by End-user ($ million)
Exhibits 97: Data Table on Market opportunity by End-user ($ million)
Exhibits 98: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 99: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 100: Chart on Comparison by Distribution Channel
Exhibits 101: Data Table on Comparison by Distribution Channel
Exhibits 102: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 104: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 105: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 106: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 108: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 109: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 110: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 112: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 113: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 114: Market opportunity by Distribution Channel ($ million)
Exhibits 115: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 116: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 117: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 118: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 119: Chart on Geographic comparison
Exhibits 120: Data Table on Geographic comparison
Exhibits 121: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on UK - Market size and forecast 2024-2029 ($ million)

Executive Summary

The following companies are recognized as the key players in the global proteasome inhibitors market: Amgen Inc., Baxter International Inc., Bristol Myers Squibb Co., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson, Kezar Life Sciences Inc., LifeSensors Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., QLi5 Therapeutics, Takeda Pharmaceutical Co. Ltd., TG Therapeutics Inc., Thermo Fisher Scientific Inc., and Tocris Bioscience.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in drug development."

According to the report, one of the major drivers for this market is the rising incidence of hematologic cancers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Amgen Inc.
Baxter International Inc.
Bristol Myers Squibb Co.
Fresenius SE and Co. KGaA
GlaxoSmithKline Plc
Johnson and Johnson
Kezar Life Sciences Inc.
LifeSensors Inc.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
QLi5 Therapeutics
Takeda Pharmaceutical Co. Ltd.
TG Therapeutics Inc.
Thermo Fisher Scientific Inc.
Tocris Bioscience

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2206EUR$2,500USD£1,923GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3530EUR$4,000USD£3,077GBP

The proteasome inhibitors market is segmented as below:

By Product

By Route Of Administration

By End-user

By Distribution Channel

By Geographical Landscape

The report on the proteasome inhibitors market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Proteasome Inhibitors Market Report 2025

Proteasome Inhibitors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

20s Proteasome Inhibitor - Pipeline Insight, 2025

Proteasome Inhibitors - Pipeline Insight, 2025

CTLA4 Inhibitors Market 2025-2029